Biomark Diagnostics Inc. (FRA:20B)
Germany · Delayed Price · Currency is EUR 0.3420
0.00 (0.00%)
At close: Apr 10, 2026
Biomark Diagnostics Market Cap
Biomark Diagnostics has a market cap or net worth of €35.94 million as of April 10, 2026. Its market cap has increased by 159.15% in one year.
Market Cap
35.94M
Enterprise Value
35.58M
Revenue
57.01K
Ranking
n/a
PE Ratio
n/a
Stock Price
€0.34
Market Cap Chart
Since November 27, 2014, Biomark Diagnostics's market cap has increased from 28.50M to 35.94M, an increase of 26.13%. That is a compound annual growth rate of 2.06%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 10, 2026 | 35.94M | 10.32% |
| Dec 30, 2025 | 32.58M | 228.85% |
| Dec 30, 2024 | 9.91M | -19.08% |
| Dec 29, 2023 | 12.24M | 23.53% |
| Dec 30, 2022 | 9.91M | -23.89% |
| Dec 30, 2021 | 13.02M | 134.71% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| PEH Wertpapier AG | 45.09M |
| Fernheizwerk Neukölln Aktiengesellschaft | 43.24M |
| BREMER LAGERHAUS-GESELLSCHAFT -Aktiengesellschaft von 1877- | 40.70M |
| Fair Value REIT-AG | 40.12M |
| Enapter AG | 39.72M |
| learnd SE | 38.56M |
| U.C.A. Aktiengesellschaft | 37.40M |
| OTRS AG | 36.22M |